People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Biotech / Pharma, Other, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pivot Bio, Inc. | — | Biotech / Pharma | Growth/Late | $622.6M | $13.0B | 2016 |
| Segetis, Inc. | — | Other | Series B | $103.2M | $16.0M | 2009 |
| Natural Dentist Inc | — | Other Health Care | Series A | $12.6M | $255.1M | 2009 |
| Amfora Inc. | — | Other | Series A | $12.3M | $92.6M | 2017 |
| Efficas Inc | — | Biotechnology | Seed | $3.9M | $140.5M | 2009 |
Roger Wyse at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Roger Wyse on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Samir Kaul | 1 | 32 |
| Matt Ocko | 1 | 13 |
| John Hamer | 1 | 7 |
| Ganesh Kishore | 1 | 7 |
| Ilya B. Nykin | 1 | 5 |
| Rajiv Singh | 1 | 4 |
| Andrew Chung | 1 | 4 |
| Peter Vitulli | 1 | 3 |
| Gerard Moufflet | 1 | 3 |
| George Stagnitti | 1 | 3 |
| Patrick Gruber | 1 | 3 |
| Tjerk De Ruiter | 1 | 3 |
| Mark A. Braman | 1 | 2 |
| James Barber | 1 | 2 |
| Jorg Riesmeier | 1 | 2 |
| George A. Stagnitti | 1 | 2 |
| Cora Leibig | 1 | 2 |
| Pascal Vinarnic | 1 | 2 |
| Sergey Selifonov | 1 | 1 |
| James R. Stoppert | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.